Genitourinary Cancer
Conference Coverage
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUC
After decades of stagnation, an almost doubling of life expectancy has set a new bar for the first-line treatment of locally advanced/metastatic...
Conference Coverage
Observation, not radiotherapy, after radical prostatectomy
The investigators observed no benefit to adjuvant radiotherapy after radical prostatectomy in patients with prostate cancer in the phase 3...
News
Doublet therapy ups survival in metastatic prostate cancer
“A clinically meaningful increase in long-term survival was observed in men diagnosed with de novo [metastatic castration-sensitive prostate...
Conference Coverage
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...
Article
Role of Prophylactic Cranial Irradiation in Small Cell Carcinoma of Urinary Bladder: Case Report and Literature Review
Article
Metastatic Urothelial Carcinoma Presenting as Mediastinal Lymphadenopathy Without Appreciable Bladder Mass in a Patient With Chronic Lymphocytic Leukemia
Latest News
Is this the best screening test for prostate cancer?
Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...
